CClinicalTrials.gg
CompletedNCT07193108Updated Feb 6, 2026

The 30-15 Intermittent Fitness Test Provides Superior Sport-Specific Sensitivity to Treadmill Testing in Elite Female Footballers

An interventional study of 30-15 Intermittent Fitness Test and Control in Change in Maximal Oxygen Uptake (VO₂Max), sponsored by Gümüşhane Universıty. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-06.

Sponsored by Gümüşhane Universıty · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Mar 2025, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

This study compares the acute aerobic, metabolic, and threshold-related physiological responses elicited by the 30-15 Intermittent Fitness Test (30-15IFT) and a treadmill-based incremental running test in elite female football players. Using a randomized crossover design, all participants completed both testing protocols with a 48-hour recovery period. Outcomes included maximal oxygen uptake, maximal running speed, heart rate responses, lactate-derived thresholds, metabolic tolerance indices, and recovery markers.

Read the detailed description

Laboratory-based treadmill tests are commonly used to assess aerobic capacity in football players; however, they lack sport-specific characteristics such as intermittent running, accelerations, and changes of direction. The 30-15 Intermittent Fitness Test (30-15IFT) has been proposed as a more ecologically valid field-based alternative.

Twenty-seven elite female football players competing in the Turkish Women's Super League completed both the 30-15IFT and a standardized treadmill incremental protocol in a randomized crossover design. Tests were separated by 48 hours and performed under controlled environmental conditions. Physiological variables including VO₂max, maximal running speed, maximal heart rate, respiratory exchange ratio, lactate-derived thresholds (OBLA), metabolic load-dependent tolerance, and post-exercise recovery markers were assessed using breath-by-breath gas analysis, heart rate monitoring, and capillary blood lactate sampling.

The study aims to determine whether the 30-15IFT elicits more sensitive and sport-specific physiological responses compared with treadmill testing, thereby supporting its use in performance monitoring and individualized training prescription in elite women's football.

02

Conditions studied

  • Change in Maximal Oxygen Uptake (VO₂Max)

Keywords

  • aerobic capacity
  • intermittent fitness assessment
  • women's football
  • metabolic response
03

In context

Lead sponsor

Gümüşhane Universıty is the lead sponsor of 34 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female football players aged 18-35 years
  • Competing in the Turkish Women's Super League
  • Minimum of 3 years of professional football experience,
  • Full participation in training and matches during the previous 6 months,
  • Ability to perform maximal exercise testing

Exclusion criteria

Exclusion Criteria:

  • Musculoskeletal injury affecting performance within the last 3 months,
  • Diagnosed cardiovascular, metabolic, or respiratory disease,
  • Any condition limiting maximal physical effort
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    30-15 Intermittent Fitness Test (30-15IFT)

    Participants performed the 30-15 Intermittent Fitness Test consisting of 30-second running bouts interspersed with 15-second passive recovery periods, with progressive increases in running speed until volitional exhaustion.

    Other: 30-15 Intermittent Fitness Test · Other: Control

  • No intervention
    CONTROL

    Inspiratory Muscle Warm-Up Non-treated group, Control

Interventions

  • Other30-15 Intermittent Fitness Test

    Participants performed the 30-15 Intermittent Fitness Test consisting of 30-second running bouts interspersed with 15-second passive recovery periods, with progressive increases in running speed until volitional exhaustion.

  • OtherControl

    Inspiratory Muscle Warm-Up Non-treated group, Control

06

What researchers measure

Primary outcomes

  1. Maximal Running Speed (MRS)

    Highest running speed achieved during each protocol.

    Time frame: DAY 1

  2. Maximal Oxygen Uptake (VO₂max)

    Maximal oxygen uptake measured via breath-by-breath gas analysis.

    Time frame: Day 1

Secondary outcomes

  1. body composition

    Body composition (BMI)

    Time frame: 1 Day

  2. Maximal Heart Rate (HRmax)

    Peak heart rate achieved during each test.

    Time frame: 1 Day

  3. Maximal Oxygen Uptake (VO₂max)

    Maximal oxygen uptake measured via breath-by-breath gas analysis.

    Time frame: DAY 1

07

Study locations

1 site
  • Gumushane Univetsity
    Gümüşhane, Kelkit 29600, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07193108
Lead sponsor
Gümüşhane Universıty
Responsible party
Coşkun YILMAZ (ASSOC. PROF., Gümüşhane Universıty) — Principal investigator
First posted
Sep 25, 2025
Start date
Mar 5, 2025
Primary completion
Mar 15, 2025
Completion
May 20, 2025
Last update
Feb 6, 2026

Study contacts

coşkun yılmaz, associate professor
principal investigator · Gümüşhane Universıty

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion